Progressive Neuroendocrine Tumors of pancreatic origin

Also known as: Pancreatic neuroendocrine tumour / Pancreatic Neuroendocrine Tumors / Pancreatic Neuroendocrine Tumor / Pancreatic Neuroendocrine Tumours / Pancreatic Neuroendocrine Tumors (pNET) / Islet cell neoplasm / Islet Cell Tumor

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB08885Aflibercept1Recruiting1
DB01590Everolimus1Completed2
DB06091Evofosfamide1Unknown Status1
DB13048PAC-11Recruiting1
DB06663Pasireotide1Completed1
DB11836Sapanisertib1Recruiting1
DB00398Sorafenib1Completed1
DB01590Everolimus1 / 2Active Not Recruiting1
DB00853Temozolomide1 / 2Active Not Recruiting1
DB12001Abemaciclib2Not Yet Recruiting1
DB11595Atezolizumab2Recruiting1
DB00112Bevacizumab2Recruiting1
DB05153Cabozantinib2Active Not Recruiting1
DB08875Cabozantinib2Active Not Recruiting1
DB01101Capecitabine2Recruiting1
DB11651Dactolisib2Completed1
DB11651Dactolisib2Terminated1
DB00530Erlotinib2Terminated1
DB01590Everolimus2Active Not Recruiting1
DB01590Everolimus2Terminated1
DB12205Ganitumab2Completed1
DB06366Pertuzumab2Terminated1
DB01268Sunitinib2Completed1
DB09256Tegafur2Recruiting1
DB00853Temozolomide2Recruiting2
DB08875Cabozantinib3Recruiting1
DB01590Everolimus3Recruiting1
DB01590Everolimus4Active Not Recruiting1
DB01268SunitinibNot AvailableCompleted1
DB01268SunitinibNot AvailableRecruiting1